Literature DB >> 35979512

Comparison of Mycobacterium tuberculosis complex Yield and Contamination Rates using Lowenstein-Jensen with and without Antibiotics in Western Kenya.

A Okumu1, K McCarthy2, J Orwa1, J Williamson3, S Musau1, H Alexander2, S Cavanaugh2, S Modi4, K Cain1,2.   

Abstract

Background: While molecular methods have been recently endorsed for diagnosis of tuberculosis (TB), mycobacterial culture remains the gold standard. Lowenstein-Jensen (LJ) is often used for the cultivation of Mycobacterium tuberculosis complex (MTBC); however contamination often renders a subset of cultures useless. We compared the MTBC yield and contamination rate of processed sputum inoculated on LJ with antibiotics (LJ PACT) to LJ without antibiotics (LJ). Methodology: Sputum samples were obtained from people living with HIV enrolled in a TB screening study in western Kenya, processed using NALC/NaOH-Na citrate, then inoculated on LJ PACT and LJ media. Cultures were evaluated weekly with growth identified as acid-fast bacilli by Ziehl-Neelsen bright-field microscopy. MTBC and nontuberculous mycobacteria (NTM) were identified by immunochromatographic and line probe assays.
Results: A total of 700 sputum samples were cultured on both LJ PACT and LJ between March and June 2012. Of those cultured on LJ PACT, 29 (4.1%) grew MTBC, 613 (87.6%) were negative, 12 (1.7%) grew NTM, and 46 (6.6%) were contaminated; on LJ, 28 (4%) grew MTBC, 553 (79%) were negative, 9 (1.3%) grew NTM, and 110 (15.7%) were contaminated. The difference in contamination on LJ PACT and LJ was statistically significant (p<0.0001), while the difference in MTBC growth was not (p=0.566).

Entities:  

Keywords:  Kenya; Lowenstein-Jensen; Nontuberculous mycobacteria; cross-sectional studies; culture techniques; diagnosis; pulmonary tuberculosis

Year:  2017        PMID: 35979512      PMCID: PMC9380436          DOI: 10.18535/jmscr/v5i8.86

Source DB:  PubMed          Journal:  J Med Sci Clin Res        ISSN: 2347-176X


  32 in total

1.  Multicenter evaluation of the MB-Redox medium compared with radiometric BACTEC system, mycobacteria growth indicator tube (MGIT), and Löwenstein-Jensen medium for detection and recovery of acid-fast bacilli.

Authors:  C Piersimoni; C Scarparo; P Cichero; M De Pezzo; I Covelli; G Gesu; D Nista; M Scagnelli; F Mandler
Journal:  Diagn Microbiol Infect Dis       Date:  1999-08       Impact factor: 2.803

2.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

3.  The resurgence of tuberculosis: is your laboratory ready?

Authors:  F C Tenover; J T Crawford; R E Huebner; L J Geiter; C R Horsburgh; R C Good
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 4.  Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance.

Authors:  Michael L Wilson
Journal:  Clin Infect Dis       Date:  2011-06       Impact factor: 9.079

Review 5.  A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis.

Authors:  R Colebunders; I Bastian
Journal:  Int J Tuberc Lung Dis       Date:  2000-02       Impact factor: 2.373

6.  Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus.

Authors:  Patama Monkongdee; Kimberly D McCarthy; Kevin P Cain; Theerawit Tasaneeyapan; H Dung Nguyen; T N Lan Nguyen; T B Yen Nguyen; Nipat Teeratakulpisarn; Nibondh Udomsantisuk; Charles Heilig; Jay K Varma
Journal:  Am J Respir Crit Care Med       Date:  2009-07-23       Impact factor: 21.405

7.  Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  Pauliina Kärpänoja; Solja T Nyberg; Miika Bergman; Tinna Voipio; Pirkko Paakkari; Pentti Huovinen; Hannu Sarkkinen
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 8.  Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.

Authors:  Mark D Perkins; Jane Cunningham
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

9.  What is the most reliable solid culture medium for tuberculosis treatment trials?

Authors:  Moses L Joloba; John L Johnson; Pei-Jean I Feng; Lorna Bozeman; Stefan V Goldberg; Karen Morgan; Phineas Gitta; Henry W Boom; Charles M Heilig; Harriet Mayanja-Kizza; Kathleen D Eisenach
Journal:  Tuberculosis (Edinb)       Date:  2014-03-19       Impact factor: 3.131

10.  Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa: comparison of native and antibiotic-bound forms.

Authors:  Sarah Sainsbury; Louise Bird; Vincenzo Rao; Sharon M Shepherd; David I Stuart; William N Hunter; Raymond J Owens; Jingshan Ren
Journal:  J Mol Biol       Date:  2010-10-23       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.